Evolent Health Overview
Evolent Health Target Price
Analysts' 12-month price predictions for EVH.
Share Price
$11.78
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-01-16 | UBSKevin Caliendo | $14 |  18.8% upside |  |
| 2025-01-15 | Truist FinancialJailendra Singh | $20 | 69.8% upside | |
| 2025-01-14 | RBC CapitalSean Dodge | $17 | 44.3% upside | |
| 2025-01-10 | JMP SecuritiesConstantine Davides | $18 | 52.8% upside | |
| 2024-11-18 | OppenheimerMohan Naidu | $28 | 137.7% upside | |
| 2024-10-17 | StephensJeff Garro | $38 | 222.6% upside | |
| 2024-08-09 | Truist FinancialJailendra Singh | $33 | 180.1% upside | |
| 2024-06-05 | RBC CapitalSean Dodge | $42 | 256.5% upside | |
| 2024-05-14 | Truist FinancialJailendra Singh | $28 | 137.7% upside | |
| 2024-04-17 | Piper SandlerJessica Tassan | $51 | 332.9% upside | |
| 2024-03-28 | Canaccord GenuityRichard Close | $44 | 273.5% upside | |
| 2022-08-03 | BTIG | $50 | 324.4% upside | |
| 2022-05-09 | Canaccord Genuity | $45 | 282% upside | |